TB 500 5 mg/BPC 157 5 mg

Dragon Pharma TB 500/BPC 157

TB 500 5 mg/BPC 157 5 mg represents the pinnacle of regenerative peptide therapy—combining two of the most powerful healing compounds into one synergistic formulation for unprecedented injury recovery and tissue repair. This expertly balanced combination delivers 5 mg of Thymosin Beta-4 (TB-500) for systemic healing and angiogenesis alongside 5 mg of Body Protection Compound-157 (BPC-157) for localized tissue regeneration and gastrointestinal protection, creating what many athletes consider the "ultimate healing stack" for sports injuries, surgical recovery, and connective tissue rehabilitation.

Each vial contains precisely formulated 5 mg aliquots of both peptides in lyophilized form, with independent laboratory verification confirming 5.43 mg TB-500 and 4.95 mg BPC-157 per vial—delivering optimal synergistic concentrations in a single convenient product. Unlike separate administration that risks dosing imbalances, this combination ensures perfect 1:1 ratio delivery, eliminating guesswork and maximizing the complementary mechanisms: TB-500's systemic circulation recruits repair cells throughout the body while BPC-157 directs focused healing at specific injury sites, with both peptides amplifying each other's regenerative effects through shared pathways involving VEGF upregulation, anti-inflammatory modulation, and cellular migration enhancement.

The performance applications for strength athletes are transformative: accelerated recovery from tendon and ligament tears common in powerlifting, enhanced repair of muscle strains from explosive movements, reduced joint inflammation from heavy loading, improved surgical recovery timelines, protection against gastrointestinal issues from oral steroid use, and potential prevention of overtraining syndrome through systemic healing support. Additionally, this stack addresses the gut-brain axis through BPC-157's enteric protection, which may improve nutrient absorption and recovery signaling during intense training phases.

Dragon Pharma's combined formulation is manufactured in EU-certified GMP facilities with strict quality controls ensuring peptide stability, accurate 1:1 ratio maintenance, and absence of cross-contamination. April 2024 third-party laboratory analysis confirms both peptides exceed 99% purity with near-perfect 5.43/4.95 mg concentrations—demonstrating Dragon Pharma's commitment to precision formulation. The lyophilized combined powder maintains both peptides' stability until reconstitution, offering athletes a convenient, cost-effective solution compared to purchasing separate vials.

Key Benefits:

• Synergistic Healing Power: TB-500's systemic repair combines with BPC-157's localized action for comprehensive injury recovery.
• Perfect 1:1 Dosing Ratio: Pre-formulated combination eliminates dosing errors and ensures optimal synergistic concentrations.
• Dual-Action Protection: BPC-157 safeguards gastrointestinal health while TB-500 repairs connective tissues stressed during training.
• Accelerated Recovery Timeline: Combined mechanisms significantly reduce healing time for acute and chronic injuries.
• Cost & Convenience Advantage: Single vial combination saves money and simplifies administration versus separate purchases.

Each vial contains 5.43 mg TB-500 and 4.95 mg BPC-157 (tested), manufactured under strict quality control standards in Dragon Pharma's certified facilities. Reconstitute with bacteriostatic water for subcutaneous administration to unleash comprehensive healing synergy.

Product Specifications

Usage Guidelines

Reconstitution: Add 2 mL of bacteriostatic water to the combination vial, yielding approximately 2.7 mg/mL TB-500 and 2.5 mg/mL BPC-157. Gently swirl until completely dissolved—avoid shaking to preserve peptide integrity. The combined formulation ensures both peptides remain stable when reconstituted together. Use within 30 days when refrigerated.

Administration: Subcutaneous injection in abdominal or thigh adipose tissue. For localized injuries, inject near affected area to maximize BPC-157's local effects while benefiting from TB-500's systemic action. Rotate injection sites. Can be administered once or twice daily depending on dosage protocol.

• Beginner Cycle (Acute Injuries - 4 weeks): 250 mcg of each peptide daily (500 mcg total). For new injuries or prevention. Ideal alongside GHK-Cu 50 mg for collagen synthesis or Deca 300 for joint support during healing.
• Intermediate Cycle (Chronic Issues - 8 weeks): 250 mcg of each peptide twice daily (1000 mcg total). For tendonitis or persistent pain. Stack with EQ 300 for enhanced recovery or Primobolan 100 for lean tissue preservation.
• Advanced Cycle (Surgical Recovery - 12 weeks): 500 mcg of each peptide daily (1000 mcg total), possibly split dosing. Post-surgery or severe trauma. Combine with IGF-1 LR3 for growth factor synergy or Dragontropin 200 for accelerated healing.

Post Cycle Therapy (PCT):

This stack is excellent during PCT to repair training damage and protect gut health while recovering hormonal balance. Continue at maintenance dose (250 mcg each daily) throughout PCT. Pair with Toremfine or Enclomiphene for comprehensive post-cycle recovery.

Liver & Gut Protection:

BPC-157 provides exceptional gastrointestinal protection during oral steroid cycles. For enhanced liver support, add TUDCA. This combination helps mitigate common side effects of aggressive cycles while promoting overall systemic health and recovery capacity.

Third-Party Lab Tested

2024-04-26

View Result

5.43 mg/4.95 mg

Note: Independent ISO-certified laboratory analysis confirms Dragon Pharma's combination formula delivers 5.43 mg TB-500 (108.6% of labeled 5 mg) and 4.95 mg BPC-157 (99% of labeled 5 mg). This precise formulation ensures optimal synergistic ratio. Additional testing confirms peptide compatibility and stability in combined form.

Storage Instructions

• Unreconstituted (Lyophilized Powder): Store at 2-8°C (36-46°F) in refrigerator. Protect from light exposure. Shelf life: 24 months from manufacture date. The combined formulation maintains both peptides' stability when stored properly. Avoid temperature fluctuations.
• After Reconstitution: Refrigerate immediately at 2-8°C (36-46°F). Use within 30 days. The peptide combination remains stable when reconstituted together. Do not freeze. If solution becomes cloudy or develops particles, discard immediately. Travel with insulated medical cooler.
• Handling Protocol: Maintain strict aseptic technique. The combined vial simplifies administration—only one reconstitution needed. Clean injection site with alcohol swab. Use sterile bacteriostatic water only. Wipe vial stopper before each puncture. Never reuse needles.